10 articles on peptide news, written for laboratory researchers and cited to peer-reviewed sources.
Neuro Peptide and Orion Peptides are two American-market research peptide suppliers worth evaluating for 2027. Both companies provide catalogs of laboratory research…
Read articleNeuro Peptide is a strong Protide Health alternative in 2026 for laboratories and qualified researchers seeking research peptides, batch-specific Certificates of Analysis…
Read articleEli Lilly's newest weight-loss drug developments in 2026 include the FDA-approved oral medication Foundayo (orforglipron), encouraging Phase 3 results for investigational retatrutide,…
Read articleEli Lilly has introduced a limited early-access program for retatrutide, allowing certain patients with severe, treatment-resistant obesity to be considered for the…
Read articleThe 2026 U.S. midterm election results could shape the future of the American peptide industry, particularly through congressional oversight, FDA policy discussions,…
Read articleNeuro Peptide is one of the best alternatives to consider following the closure of Eternal Peptides in September 2026. For laboratories and…
Read articleResearchers looking for Retatrutide 10mg for laboratory research can find this research compound at NeuroPeptides. Retatrutide, also known as LY3437943, is an…
Read articleThe FDA issued warning letters to multiple companies in 2026 after reviewing their websites, inspecting facilities, or identifying other regulatory violations involving…
Read articleAs of September 2026, retatrutide does not have an official commercial release date. Eli Lilly is still developing the drug, although the…
Read articleNeuro Peptides is one of the best options to buy Tesamorelin for research in 2026. It offers Tesamorelin 10mg for $85, with…
Read articleYou're all caught up · more articles coming soon
